Heritability of Magnetic Resonance Imaging (MRI) Traits in Alzheimer Disease Cases and Their Siblings in the MIRAGE Study

Magnetic resonance imaging (MRI) traits can serve as more specific measures of degenerative or cerebrovascular brain injury than can be ascertained through personal history, risk factors, clinical signs, or symptoms. They are potentially useful intermediate phenotypes for genetic studies of Alzheimer disease (AD). Recent studies have estimated heritability of white matter hyperintensity (WMH) among cognitively normal family members to be between 0.55 and 0.73. Persons discordant for AD are expected to have substantially different MRI phenotype distributions; our goal was to determine whether MRI traits in siblings discordant for AD are heritable. We measured cerebral atrophy, medial temporal atrophy (MTA), WMH, and a rating of cerebrovascular disease (CVR) via MRI in 815 participants from 424 families of the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study. Residual heritability after adjustment for covariates ranged from 0.17 (P=0.009) for MTA to 0.57 (P=10−7) for CVR. The number of APOE-ϵ4 alleles was significantly associated with WMH (P=0.01) and CVR (P=0.005) but not cerebral atrophy (P=0.25) or MTA (P=0.83). Heritability remained significant and high after adjusting for APOE genotype, suggesting that a substantial proportion of the additive genetic variation in these MRI traits is explained by other genes. In the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study of AD-discordant siblings, MRI traits are heritable and are potential endophenotypes for genetic association studies.

[1]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  K. Lunetta,et al.  Magnetic Resonance Imaging Traits in Siblings Discordant for Alzheimer Disease , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[3]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[4]  M. Fornage,et al.  Genomic Susceptibility Loci for Brain Atrophy in Hypertensive Sibships From the GENOA Study , 2005, Hypertension.

[5]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.

[6]  R B D'Agostino,et al.  Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.

[7]  Charles DeCarli,et al.  Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.

[8]  Charles DeCarli,et al.  Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.

[9]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[10]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[11]  M. Fornage,et al.  Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.

[12]  Richard Mayeux,et al.  The Genetics of Adult-Onset Neuropsychiatric Disease: Complexities and Conundra? , 2003, Science.

[13]  John Breitner,et al.  Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.

[14]  V. Gallai†,et al.  Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. , 2003, Archives of neurology.

[15]  C. DeCarli The Role of Cerebrovascular Disease in Dementia , 2003, The neurologist.

[16]  J. Schneider,et al.  Relation of cerebral infarctions to dementia and cognitive function in older persons , 2003, Neurology.

[17]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[18]  Matthijs Oudkerk,et al.  Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.

[19]  Charles DeCarli,et al.  Quantitative genetic modeling of regional brain volumes and cognitive performance in older male twins , 2002, Biological Psychology.

[20]  M H Buonocore,et al.  Brain structure and cognition in a community sample of elderly Latinos , 2002, Neurology.

[21]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[22]  R. Green,et al.  Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.

[23]  Tyrone D. Cannon,et al.  Genetic influences on brain structure , 2001, Nature Neuroscience.

[24]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[25]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[26]  R. Green,et al.  Reliability of Information Collected by Proxy in Family Studies of Alzheimer’s Disease , 2001, Neuroepidemiology.

[27]  E. Mori,et al.  Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease: A Quantitative Study , 2000, Stroke.

[28]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[29]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[30]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[31]  P. Scheltens,et al.  Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias , 1999 .

[32]  C. DeCarli,et al.  Impact of Apolipoprotein E ε4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study , 1999 .

[33]  Nick C Fox,et al.  Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease , 1999, The Lancet.

[34]  M N Rossor,et al.  Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.

[35]  T. Manolio,et al.  Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. , 1998, Archives of neurology.

[36]  B L Miller,et al.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.

[37]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[38]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[39]  Nick C Fox,et al.  Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease , 1997, Journal of magnetic resonance imaging : JMRI.

[40]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[41]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[42]  Nick C. Fox,et al.  The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.

[43]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[44]  F. Fazekas,et al.  Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.

[45]  Nick C Fox,et al.  Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.

[46]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[47]  W. Tsai,et al.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. , 1996, American journal of human genetics.

[48]  J. Growdon,et al.  Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study , 1996, Neurology.

[49]  P. Scheltens,et al.  Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.

[50]  Barry Horwitz,et al.  Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type , 1995, Psychiatry Research.

[51]  S. Gauthier,et al.  Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies , 1994, Annals of neurology.

[52]  J. Growdon,et al.  Interrater agreement for diagnosis of Alzheimer's disease , 1994, Neurology.

[53]  R. Kronmal,et al.  Magnetic Resonance Abnormalities and Cardiovascular Disease in Older Adults: The Cardiovascular Health Study , 1994, Stroke.

[54]  W. Burke,et al.  Validation of a Telephone Version of the Mini‐Mental State Examination , 1992, Journal of the American Geriatrics Society.

[55]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[56]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[57]  W. Jagust,et al.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.

[58]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[59]  H. Soininen,et al.  Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer’s Disease , 2002, CNS drugs.

[60]  A Pfefferbaum,et al.  Heritability of hippocampal size in elderly twin men: Equivalent influence from genes and environment , 2001, Hippocampus.

[61]  C. DeCarli,et al.  Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. , 1999, Stroke.

[62]  P. Scheltens,et al.  Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. , 1999, Archives of neurology.

[63]  M L Bots,et al.  Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study. , 1998, Journal of neural transmission. Supplementum.

[64]  F Barkhof,et al.  Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging , 1997, European Neurology.